Fig. 6

Correlation of SFXN1 expression with immune cell infiltration, inhibitory immune molecules, and immunotherapy response in the TCGA LUAD dataset. A-B The difference of stroma score (A), immune score (B), estimate score (C) and tumor purity (D) between low and high SFXN1 expression group. E-F The 28 immune cell composition (E) and immune exhaustion molecules (F) expression in different SFXN1 expression in LUAD patients. G-I Immunotherapy response biomarkers, including tumor immune dysfunction and exclusion (TIDE) score (G), T-cell exclusion score (H) and T-cell dysfunction score (I), between SFXN1 low and high expression group